Symbols

NPCE

NeuroPace·NASDAQ

--(--)

NPCE fundamentals

NPCE Q4 2025 Earnings

NeuroPace (NPCE) released its earnings on Mar 3, 2026: revenue was 26.59M (YoY +23.86%), beat estimates; EPS was -0.08 (YoY +55.56%), beat estimates.

Revenue / YoY

26.59M

+23.86%

EPS / YoY

-0.08

+55.56%

Report date

Mar 3, 2026

NPCE Earnings Call Summary for Q4,2025

25% RNS System growth: 2026 epilepsy AI adoption (75%+ Seizure ID penetration).

Earnings

EPS

Revenue

Revenue & Expenses

NPCE has released its 2025 Q4 earnings report, with revenue of 26.59M, reflecting a YoY change of 23.86%, and net profit of -2.73M, showing a YoY change of 48.02%. The Sankey diagram below clearly presents NPCE's revenue sources and cost distribution.

Key Indicators

NeuroPace (NPCE) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

NeuroPace (NPCE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

NeuroPace (NPCE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

NeuroPace (NPCE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown